Search
Caris Life Sciences Inc
CAIAdd to Watchlist
29.980USD
-0.940-3.04%
Close 09-17 16:00（ET）
8.47BMarket Cap
LossP/E TTM
After-hours 16:12 (ET)29.810USD-0.135-0.45%
After-hours 16:12 (ET)Caris Life Sciences Inc (CAI) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Caris Life Sciences Inc in the past month.
Buy
5 Strong Buy
4 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
27.000USD-5.26%
CAI Analyst Recommendation Trends
In the current month, CAI has received 4 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. CAI average Analyst price target in the last month is 27.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
6
5
5
4
4
4
4
4
5
4
4
4
4
4
3
3
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
13
10
10
9
9
8
CAI Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, CAI EPS is projected to reach 0.035 in FY2026Q3, following reported EPS of -0.002 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.03
-0.02
0.01
0.04
0.11
Actual
0.29
-0.00
-0.00
--
--
Surprise
+816.06%
+91.76%
-122.50%
--
--
FAQs
What is Caris Life Sciences Inc's expected revenue for the next quarter?
Caris Life Sciences Inc's expected revenue is 255.56M.
What is Caris Life Sciences Inc's price target?
Analysts forecast that Caris Life Sciences Inc's price target is USD 27.00, with the highest forecast at USD 33.00 and the lowest forecast at USD 22.00.
How have Caris Life Sciences IncCAI's recent earnings per share performed?
The market expectation was USD -0.00, while Caris Life Sciences IncCAI's earnings per share (EPS) for the previous quarter was USD -0.00. EPS for the next quarter is expected at USD 0.04.
What is the analyst rating for Caris Life Sciences Inc?
Based on the ratings of Caris Life Sciences Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.